Whitehawk Therapeutics, Inc. Common Stock

WHWK XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

210M

Short interest (May 15)

1.7%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.95%

↑ 58.9%

Available Shares

↑ 15.8%

Price Chart

Company Overview

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001422142

Asset Type: CS

Market Data

Market Cap: $206,711,295

Employees: 23

Status: Active

Short Interest

Current Borrow Fee 0.95%

Range: 0.45% - 0.95%

Available Shares 2M

Range: 1.5M - 1.6M

Recent Changes

Fee Change: ↑ 22.4%

Available Change: ↓ 2.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime